FNAM Evolutionary Genomics
Company profile
Ticker
FNAM
Exchange
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
Fona, Inc.
SEC CIK
Corporate docs
IRS number
264369698
Investment data
Securities sold
Number of investors
Calendar
31 Mar 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 215.84K | 215.84K | 215.84K | 215.84K | 215.84K | 215.84K |
Cash burn (monthly) | 34.93K | (positive/no burn) | 621.62K | 240.98K | 516.08K | 191.44K |
Cash used (since last report) | 120K | n/a | 2.14M | 827.79K | 1.77M | 657.62K |
Cash remaining | 95.84K | n/a | -1.92M | -611.95K | -1.56M | -441.78K |
Runway (months of cash) | 2.7 | n/a | -3.1 | -2.5 | -3.0 | -2.3 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 20 | Steve B Warnecke | Common Stock | Gift | Dispose G | No | No | 0 | 15,000 | 0 | 1,902,088 |
30 Dec 20 | Steve B Warnecke | Common Stock | Gift | Dispose G | No | No | 0 | 15,000 | 0 | 1,917,088 |
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
agreed, anniversary, arrive, awaiting, bankruptcy, batch, behavior, breach, confer, consent, contrary, corroborative, DCA, deoxyribonucleic, detailing, Disaster, discretion, Dole, effort, EIDL, eligibility, eligible, emphasized, exacerbate, experienced, fifty, finite, forgiven, FW, goal, Governor, grew, heightened, inclusive, indeterminable, infection, Injury, knowledge, Latin, loan, lowered, macroeconomic, Mexico, million, Musaceae, outbreak, pandemic, Paycheck, Payroll, Peru, pervasive, popularly, PPP, promissory, propagated, propagation, random, realm, reissuance, Relief, repaid, repayment, SBA, secondary, spread, staggering, supply, supplying, tangible, taste, termination, thirty, threshold, underway, UW, verifying
Removed:
Accelerator, accurately, AMT, anticipated, assert, assigned, classification, classified, comparative, complement, complementary, confidence, considerably, consideration, create, customer, deductibility, DIRIGNET, disclose, discounted, diversion, divert, diverted, earliest, eliminating, Eventually, evolve, expand, expensive, favor, fee, fiber, governing, grow, higher, indefinite, informational, integrating, intended, invest, investigation, investing, investor, judgment, lessee, listing, lived, longer, lose, Master, materialize, modified, necessitated, Nguyen, oil, operational, OTC, oversee, pattern, practical, practice, presented, promising, prospect, randomdeoxyribonucleic, reach, reduction, reevaluate, Reform, relating, reload, resolve, resolved, retrospective, ROU, round, SCN, seeking, specificity, suitable, taxation, territorial, tolerate, transition, uncertainty, varying, visible, Wall, worldwide
Financial reports
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
13 Nov 20
10-Q
2020 Q2
Quarterly report
19 Aug 20
NT 10-Q
Notice of late quarterly filing
14 Aug 20
10-Q
2020 Q1
Quarterly report
12 May 20
10-K/A
2019 FY
Annual report (amended)
24 Apr 20
10-K
2019 FY
Annual report
30 Mar 20
10-Q
2019 Q3
Quarterly report
17 Oct 19
10-Q
2019 Q2
Quarterly report
12 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
Current reports
8-K
Changes in Registrant's Certifying Accountant
4 Oct 18
8-K
Other Events
21 May 18
8-K
Other Events
8 Sep 16
8-K
Unregistered Sales of Equity Securities
24 Feb 16
8-K
Completion of Acquisition or Disposition of Assets
22 Oct 15
8-K
Departure of Directors or Certain Officers
29 Sep 15
8-K/A
Entry into a Material Definitive Agreement
7 Oct 14
8-K
Entry into a Material Definitive Agreement
6 Oct 14
8-K
Entry into a Material Definitive Agreement
11 Jun 14
Registration and prospectus
D
$1.05M in equity, sold $490K, 4 investors
15 May 19
D
$3.15M in equity, sold $2.88M, 25 investors
10 Mar 16
424B3
Prospectus supplement
10 Sep 15
S-4/A
Registration of securities issued in business combination transactions (amended)
27 Aug 15
S-4/A
Registration of securities issued in business combination transactions (amended)
29 Jul 15
S-4/A
Registration of securities issued in business combination transactions (amended)
1 Jul 15
S-4
Registration of securities issued in business combination transactions
1 Apr 15
10-12G
Registration of securities
22 Sep 10
Proxies
No filings
Other
EFFECT
Notice of effectiveness
10 Sep 15
CORRESP
Correspondence with SEC
8 Sep 15
UPLOAD
Letter from SEC
20 Jul 15
CORRESP
Correspondence with SEC
5 Jul 15
UPLOAD
Letter from SEC
30 Apr 15
UPLOAD
Letter from SEC
1 Aug 13
CORRESP
Correspondence with SEC
18 Feb 13
UPLOAD
Letter from SEC
12 Nov 12
CORRESP
Correspondence with SEC
4 Nov 12
UPLOAD
Letter from SEC
13 Sep 12
Ownership
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
4 Jan 21
4
EVOLUTIONARY GENOMICS / Mark Virgil Boggess ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / Virginia P. Orndorff ownership change
29 Oct 19
4
EVOLUTIONARY GENOMICS / STEVE B WARNECKE ownership change
8 Sep 16
3
Fona / Mark Virgil Boggess ownership change
20 Oct 15
3
Fona / Virginia P. Orndorff ownership change
20 Oct 15
SC 13D/A
Fona, Inc.
7 Oct 14
SC 13D
Fona, Inc.
15 Jun 14